Annual Current Liabilities
$11.40 M
-$1.28 M-10.10%
December 31, 2023
Summary
- As of March 10, 2025, INKT annual total current liabilities is $11.40 million, with the most recent change of -$1.28 million (-10.10%) on December 31, 2023.
- During the last 3 years, INKT annual current liabilities has fallen by -$2.82 million (-19.83%).
- INKT annual current liabilities is now -30.75% below its all-time high of $16.46 million, reached on December 31, 2021.
Performance
INKT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$7.40 M
-$2.75 M-27.08%
September 30, 2024
Summary
- As of March 10, 2025, INKT quarterly total current liabilities is $7.40 million, with the most recent change of -$2.75 million (-27.08%) on September 30, 2024.
- Over the past year, INKT quarterly current liabilities has stayed the same.
- INKT quarterly current liabilities is now -90.82% below its all-time high of $80.56 million, reached on September 30, 2021.
Performance
INKT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
INKT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.1% | 0.0% |
| 3 y3 years | -19.8% | 0.0% |
| 5 y5 years | +53.7% | 0.0% |
INKT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.8% | at low | -60.7% | at low |
| 5 y | 5-year | -30.8% | +53.7% | -90.8% | at low |
| alltime | all time | -30.8% | +53.7% | -90.8% | at low |
MiNK Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.40 M(-27.1%) |
| Jun 2024 | - | $10.15 M(-8.7%) |
| Mar 2024 | - | $11.11 M(-2.6%) |
| Dec 2023 | $11.40 M(-10.1%) | $11.40 M(+9.7%) |
| Sep 2023 | - | $10.39 M(-9.3%) |
| Jun 2023 | - | $11.46 M(+1.9%) |
| Mar 2023 | - | $11.25 M(-11.3%) |
| Dec 2022 | $12.68 M | $12.68 M(-31.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $18.45 M(+5.9%) |
| Jun 2022 | - | $17.43 M(-7.5%) |
| Mar 2022 | - | $18.83 M(+14.4%) |
| Dec 2021 | $16.46 M(+15.8%) | $16.46 M(-79.6%) |
| Sep 2021 | - | $80.56 M(+19.3%) |
| Jun 2021 | - | $67.55 M(+374.9%) |
| Dec 2020 | $14.22 M(+91.7%) | $14.22 M |
| Dec 2019 | $7.42 M | - |
FAQ
- What is MiNK Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for MiNK Therapeutics?
- What is MiNK Therapeutics annual current liabilities year-on-year change?
- What is MiNK Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly current liabilities year-on-year change?
What is MiNK Therapeutics annual total current liabilities?
The current annual current liabilities of INKT is $11.40 M
What is the all time high annual current liabilities for MiNK Therapeutics?
MiNK Therapeutics all-time high annual total current liabilities is $16.46 M
What is MiNK Therapeutics annual current liabilities year-on-year change?
Over the past year, INKT annual total current liabilities has changed by -$1.28 M (-10.10%)
What is MiNK Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of INKT is $7.40 M
What is the all time high quarterly current liabilities for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly total current liabilities is $80.56 M
What is MiNK Therapeutics quarterly current liabilities year-on-year change?
Over the past year, INKT quarterly total current liabilities has changed by $0.00 (0.00%)